Parkinson’s disease is characterized by the presence of abnormal, intraneuronal α-synuclein
aggregates, which may propagate from cell-to-cell in a prion-like manner. However, it …

In Parkinson disease (PD), pathological processes and neurodegeneration begin long
before the cardinal motor symptoms develop and enable clinical diagnosis. In this prodromal …

Aggregation of alpha-synuclein into inclusion bodies, termed Lewy pathology, is a defining
feature of Parkinson's disease (PD) and Dementia with Lewy bodies (DLB). In the majority of …

The dual-hit hypothesis of Parkinson’s disease (PD) originally postulated that a neurotropic
pathogen leads to formation of α-synuclein pathology in the olfactory bulb (OB) and dorsal …

Braak's hypothesis has been extremely influential over the last two decades. However,
neuropathological and clinical evidence suggest that the model does not conform to all patients …

Parkinson’s disease (PD) is the second most common neurodegenerative disease. Patients
show deposits of pathological, aggregated α-synuclein not only in the brain but throughout …

Background & Aims Obeticholic acid (OCA) is an agonist of the nuclear bile acid receptor
farnesoid X receptor, which regulates hepatic bile acid metabolism. We tested whether OCA …

Background Patients with Parkinson's disease (PD) often develop dementia, but the underlying
substrate is incompletely understood. Generalized synaptic degeneration may contribute …

Cholinergic changes play a fundamental role in the natural history of dementia with Lewy
bodies and Lewy body disease in general. Despite important achievements in the field of …

Background: We have hypothesized that Parkinson’s disease (PD) comprises two subtypes.
Brain-first, where pathogenic α-synuclein initially forms unilaterally in one hemisphere …